Investor Overview

VYNE Therapeutics™ is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

2.22

Mar. 01, 2024 16:00:00
  • Change -0.01 (-0.4484%)
  • Volume 90,966
  • Today's Open 2.18
  • Previous Close 2.23
  • Today's High 2.25
  • Today's Low 2.11
  • 52 Week High 8.73
  • 52 Week Low 1.67